Nuwellis, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
MINNEAPOLIS, Nov. 14, 2023 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq:NUWE) today announced that, effective November 14, 2023, the Company’s independent directors approved equity awards under Nuwellis’ 2021 Inducement Plan, as material inducements to five individuals entering into employment with the Company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4), which also requires a public announcement of equity awards that are not made under a stockholder-approved equity plan.
Related news for (NUWE)
- Nuwellis Announces 92% Survival in Children with Acute Kidney Injury (AKI), Fluid Overload or Congenital Kidney Failure Following Treatment with Aquadex®
- 24/7 Market News Snapshot 30 September, 2025 – Nuwellis, Inc. Common Stock (NASDAQ:NUWE)
- Nuwellis’ Vivian Receives $3 Million NIH Grant to Accelerate Pediatric Platform and Strengthen Fluid-Management Portfolio
- 24/7 Market News Snapshot 09 September, 2025 – Nuwellis, Inc. Common Stock (NASDAQ:NUWE)
- MoBot’s Stock Market Highlights – 08/18/25 02:00 PM